Ivermectin reduces in vivo coronavirus infection in a mouse experimental model

The objective of this study was to test the effectiveness of ivermectin for the treatment of mouse hepatitis virus (MHV), a type 2 family RNA coronavirus similar to SARS-CoV-2. Female BALB/cJ mice were infected with 6,000 PFU of MHV-A59 (group infected, n = 20) or infected and then immediately treat...

Descrizione completa

Dettagli Bibliografici

Autore principale:	Arévalo, Ana Paula (author)
Altri autori:	Pagotto, Romina (author), Pórfido Barayoli, Jorge Luis (author), Daghero Villanueva, Hellen (author), Segovia, Mercedes (author), Yamasaki, Kanji (author), Varela Cruces, María Belén (author), Hill, Marcelo (author), Verdes García, José Manuel (author), Duhalde Vega, Maite (author), Bollati-Fogolín, Mariela (author), Crispo, Martina (author)
Natura:	article
Lingua:	inglese
Pubblicazione:	2021
Soggetti:	INFECCION EXPERIMENTAL RATONES IVERMECTINA CORONAVIRUS CAUSANTE DEL SINDROME RESPIRATORIO AGUDO SEVERO TERAPIA
Accesso online:	https://hdl.handle.net/20.500.12008/48337 https://doi.org/10.1038/s41598-021-86679-0
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!